Lin Zhimiao, Zhao Jiahui, Nitoiu Daniela, Scott Claire A, Plagnol Vincent, Smith Frances J D, Wilson Neil J, Cole Christian, Schwartz Mary E, McLean W H Irwin, Wang Huijun, Feng Cheng, Duo Lina, Zhou Eray Yihui, Ren Yali, Dai Lanlan, Chen Yulan, Zhang Jianguo, Xu Xun, O'Toole Edel A, Kelsell David P, Yang Yong
Department of Dermatology, Peking University First Hospital, Beijing 100034, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing 100034, China.
Centre for Cutaneous Research, The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Am J Hum Genet. 2015 Mar 5;96(3):440-7. doi: 10.1016/j.ajhg.2014.12.026. Epub 2015 Feb 12.
Calpastatin is an endogenous specific inhibitor of calpain, a calcium-dependent cysteine protease. Here we show that loss-of-function mutations in calpastatin (CAST) are the genetic causes of an autosomal-recessive condition characterized by generalized peeling skin, leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, which we propose to be given the acronym PLACK syndrome. In affected individuals with PLACK syndrome from three families of different ethnicities, we identified homozygous mutations (c.607dup, c.424A>T, and c.1750delG) in CAST, all of which were predicted to encode truncated proteins (p.Ile203Asnfs∗8, p.Lys142∗, and p.Val584Trpfs∗37). Immunohistochemistry shows that staining of calpastatin is reduced in skin from affected individuals. Transmission electron microscopy revealed widening of intercellular spaces with chromatin condensation and margination in the upper stratum spinosum in lesional skin, suggesting impaired intercellular adhesion as well as keratinocyte apoptosis. A significant increase of apoptotic keratinocytes was also observed in TUNEL assays. In vitro studies utilizing siRNA-mediated CAST knockdown revealed a role for calpastatin in keratinocyte adhesion. In summary, we describe PLACK syndrome, as a clinical entity of defective epidermal adhesion, caused by loss-of-function mutations in CAST.
钙蛋白酶抑制蛋白是钙蛋白酶的一种内源性特异性抑制剂,钙蛋白酶是一种钙依赖性半胱氨酸蛋白酶。在此我们表明,钙蛋白酶抑制蛋白(CAST)功能丧失突变是一种常染色体隐性疾病的遗传病因,该疾病的特征为全身性皮肤脱屑、白甲、肢端点状角化病、唇炎和指节垫,我们建议将其简称为PLACK综合征。在来自三个不同种族家庭的患有PLACK综合征的受影响个体中,我们在CAST中鉴定出纯合突变(c.607dup、c.424A>T和c.1750delG),所有这些突变预计都会编码截短蛋白(p.Ile203Asnfs∗8、p.Lys142∗和p.Val584Trpfs∗37)。免疫组织化学显示,受影响个体皮肤中钙蛋白酶抑制蛋白的染色减少。透射电子显微镜显示,病变皮肤棘层上部细胞间空间增宽,伴有染色质凝聚和边缘化,提示细胞间黏附受损以及角质形成细胞凋亡。在TUNEL检测中也观察到凋亡角质形成细胞显著增加。利用小干扰RNA介导的CAST敲低进行的体外研究揭示了钙蛋白酶抑制蛋白在角质形成细胞黏附中的作用。总之,我们将PLACK综合征描述为由CAST功能丧失突变导致的一种表皮黏附缺陷的临床实体。